BRIAN KLEIN: Open Payments
NPI 1700134640 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,289 in 30 payments from 11 companies in 2025. Trend: 2023 $1,908 · 2024 $1,737 · 2025 $5,289
Consulting: $3,060Travel & lodging: $1,202Food & beverage: $1,023Education: $5
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $4,550 |
| ABBVIE INC. | 8 | $253 |
| Regeneron Healthcare Solutions, Inc. | 4 | $136 |
| Organon LLC | 1 | $122 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Lilly USA, LLC | 1 | $39 |
| Galderma Laboratories, L.P. | 1 | $37 |
| GENZYME CORPORATION | 1 | $36 |
| UCB, Inc. | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
Products named: Odomzo, DUPIXENT, SKYRIZI, VTAMA, RINVOQ, Sotyktu, ILUMYA, EBGLYSS.
Industry payments across FL — which companies pay providers there.
